The Healthcare industry, composed of companies in biotechnology, pharmaceuticals, life sciences, serviced care, and medical devices, has been rapidly evolving. With new medical equipment, procedures, and clinical drugs constantly rolling out, the healthcare industry has grown and will continue to grow and evolve with large healthcare companies acquiring smaller companies to expand their treatment, research, and service capabilities.
The issues driving the healthcare M&A surge are rather blatant. Providers can no longer sustain the demands of a shifting payment structure, evolving technology, and increasing patient awareness as a result. Mergers continue to draw appeal to those trying to meet the quadruple aim of increasing care access, reducing cost, improving care quality, and improving staff satisfaction.
For buyers, healthcare mergers are attractive due to the opportunity and security offered by senior care as aging baby boomers pour more money into the market. Despite the substantial pace of M&A, the market remains relatively fragmented due to uncertainties, including evolving technology requirements, the future of the Affordable Care Act, and the implementation of value-based reimbursement and alternative payment models industry.
For further information, please contact us.